{"id":"https://openalex.org/W3008220482","doi":null,"title":"Pre-Clinical Assessment of MCL-1 as a Therapeutic Target in T-Cell Lymphomas","display_name":"Pre-Clinical Assessment of MCL-1 as a Therapeutic Target in T-Cell Lymphomas","publication_year":2018,"publication_date":"2018-03-23","ids":{"openalex":"https://openalex.org/W3008220482","mag":"3008220482"},"language":"en","primary_location":{"id":"pmh:oai:dash.harvard.edu:1/37945088","doi":null,"is_oa":true,"landing_page_url":"http://nrs.harvard.edu/urn-3:HUL.InstRepos:37945088","pdf_url":"http://nrs.harvard.edu/urn-3:HUL.InstRepos:37945088","source":{"id":"https://openalex.org/S4306401540","display_name":"Digital Access to Scholarship at Harvard (DASH) (Harvard University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I136199984","host_organization_name":"Harvard University","host_organization_lineage":["https://openalex.org/I136199984"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Thesis or Dissertation"},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://nrs.harvard.edu/urn-3:HUL.InstRepos:37945088","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038598397","display_name":"Amanda L. Christie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Amanda L. Christie","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5038598397"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.9057999849319458,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.9057999849319458,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.08749999850988388,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mcl-1","display_name":"Mcl-1","score":0.9990000128746033},{"id":"https://openalex.org/keywords/t-cell-non-hodgkin-lymphoma","display_name":"T-cell non-Hodgkin lymphoma","score":0.9860000014305115},{"id":"https://openalex.org/keywords/bcl-2-family-proteins","display_name":"Bcl-2 family proteins","score":0.8259999752044678},{"id":"https://openalex.org/keywords/apoptosis-evasion","display_name":"apoptosis evasion","score":0.8169999718666077},{"id":"https://openalex.org/keywords/bh3-profiling","display_name":"BH3 profiling","score":0.7720000147819519},{"id":"https://openalex.org/keywords/azd5991","display_name":"AZD5991","score":0.9319999814033508},{"id":"https://openalex.org/keywords/mcl-1-inhibitors","display_name":"Mcl-1 inhibitors","score":0.8799999952316284},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.8870000243186951},{"id":"https://openalex.org/keywords/copy-number-variation","display_name":"copy number variation","score":0.777999997138977},{"id":"https://openalex.org/keywords/drug-sensitivity-biomarkers","display_name":"drug sensitivity biomarkers","score":0.5699999928474426},{"id":"https://openalex.org/keywords/relapsed-refractory-lymphoma","display_name":"relapsed/refractory lymphoma","score":0.8889999985694885},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.8019999861717224}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49157246947288513},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.48948800563812256},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.41432806849479675}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:dash.harvard.edu:1/37945088","doi":null,"is_oa":true,"landing_page_url":"http://nrs.harvard.edu/urn-3:HUL.InstRepos:37945088","pdf_url":"http://nrs.harvard.edu/urn-3:HUL.InstRepos:37945088","source":{"id":"https://openalex.org/S4306401540","display_name":"Digital Access to Scholarship at Harvard (DASH) (Harvard University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I136199984","host_organization_name":"Harvard University","host_organization_lineage":["https://openalex.org/I136199984"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Thesis or Dissertation"},{"id":"mag:3008220482","doi":null,"is_oa":false,"landing_page_url":"https://dash.harvard.edu/handle/1/37945088","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:oai:dash.harvard.edu:1/37945088","doi":null,"is_oa":true,"landing_page_url":"http://nrs.harvard.edu/urn-3:HUL.InstRepos:37945088","pdf_url":"http://nrs.harvard.edu/urn-3:HUL.InstRepos:37945088","source":{"id":"https://openalex.org/S4306401540","display_name":"Digital Access to Scholarship at Harvard (DASH) (Harvard University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I136199984","host_organization_name":"Harvard University","host_organization_lineage":["https://openalex.org/I136199984"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Thesis or Dissertation"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3008220482.pdf","grobid_xml":"https://content.openalex.org/works/W3008220482.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W1993858215","https://openalex.org/W2018817212","https://openalex.org/W2020055542","https://openalex.org/W2028286408","https://openalex.org/W2033846919","https://openalex.org/W2034269086","https://openalex.org/W2043398720","https://openalex.org/W2048563772","https://openalex.org/W2076738134","https://openalex.org/W2118952409","https://openalex.org/W2122147796","https://openalex.org/W2141795335","https://openalex.org/W2143204311","https://openalex.org/W2154564841","https://openalex.org/W2165056381","https://openalex.org/W2269578998","https://openalex.org/W2280585894","https://openalex.org/W2293934827","https://openalex.org/W2310716991","https://openalex.org/W2311842365","https://openalex.org/W2338801032","https://openalex.org/W2360764264","https://openalex.org/W2496540777","https://openalex.org/W2534349779","https://openalex.org/W2546559417","https://openalex.org/W2589060305"],"related_works":["https://openalex.org/W2293934827","https://openalex.org/W2902552812","https://openalex.org/W2979831370","https://openalex.org/W4407192529","https://openalex.org/W3095292609","https://openalex.org/W2496540777","https://openalex.org/W4389248716","https://openalex.org/W3135673850","https://openalex.org/W4389220463","https://openalex.org/W3180766567"],"abstract_inverted_index":{"Patients":[0],"with":[1,244],"T-cell":[2,180],"non-Hodgkin":[3],"lymphoma":[4],"(T-NHL)":[5],"face":[6],"a":[7,33,56,62,110,144,165,195,259],"particularly":[8],"poor":[9],"prognosis":[10],"and":[11,20,38,43,66,139,151,223],"are":[12,74,269],"in":[13,25,76,125,186,232,238],"desperate":[14],"need":[15],"of":[16,30,35,52,61,64,71,93,104,112,146,179,189,205,235,241],"improved":[17],"targeted":[18],"therapies":[19],"rational":[21],"combination":[22],"strategies,":[23],"especially":[24],"the":[26,72,100,105,130,159,185],"relapsed/refractory":[27],"setting.":[28],"Evasion":[29],"apoptosis":[31,54,90,161],"is":[32,55,91,99],"hallmark":[34],"cancer":[36],"cells":[37],"contributes":[39],"to":[40,212,263],"drug":[41,221],"resistance":[42],"tumor":[44],"progression":[45],"(Hanahan":[46],"&":[47],"Weinberg,":[48],"2000).":[49],"Thus,":[50],"activation":[51],"intrinsic":[53,160],"promising":[57],"avenue":[58],"for":[59,258],"treatment":[60],"variety":[63],"cancers,":[65],"drugs":[67],"targeting":[68],"specific":[69],"parts":[70],"pathway":[73],"already":[75],"clinical":[77],"use":[78],"(Ashkenazi":[79],"et":[80,117],"al.,":[81,118],"2017).":[82],"A":[83],"common":[84],"mechanism":[85],"by":[86,134,202,251],"which":[87],"lymphomas":[88,267],"evade":[89],"upregulation":[92],"anti-apoptotic":[94],"BCL-2":[95,106,131],"family":[96,107,132],"members.":[97],"MCL-1":[98,174,191,225,236],"most":[101],"universally":[102],"expressed":[103],"members":[108,133],"across":[109,143,176],"panel":[111],"different":[113],"T-NHL":[114,148,242],"subtypes":[115,178],"(Spinner":[116],"2016),":[119],"making":[120],"it":[121],"an":[122,190],"attractive":[123],"target":[124],"T-NHL.":[126],"Here":[127],"we":[128,163,183],"characterize":[129],"protein":[135,226],"abundance,":[136],"RNA":[137,229],"expression,":[138],"copy":[140],"number":[141],"variations":[142],"set":[145],"21":[147,206],"cell":[149,197,208,266],"lines":[150,209],"5":[152],"patient-derived":[153],"xenograft":[154],"models.":[155],"To":[156],"functionally":[157],"assess":[158],"pathway,":[162],"utilized":[164],"functional":[166,245],"assay":[167],"called":[168],"BH3":[169,171,252],"profiling.":[170,253],"profiling":[172],"identified":[173],"dependence":[175,246],"multiple":[177],"lymphomas.":[181],"Subsequently":[182],"tested":[184,207],"vitro":[187],"activity":[188],"inhibitor,":[192],"AZD5991,":[193],"using":[194],"luminescent":[196],"viability":[198],"assay.":[199],"As":[200],"predicted":[201],"BH3-profiling,":[203],"15":[204],"showed":[210],"sensitivity":[211,222],"AZD5991.":[213],"In":[214],"contrast,":[215],"there":[216],"was":[217],"little":[218],"correlation":[219],"between":[220],"either":[224],"abundance":[227],"or":[228],"expression.":[230],"The":[231],"vivo":[233],"efficacy":[234],"inhibition":[237],"PDX":[239],"models":[240],"correlated":[243],"on":[247,271],"MCL-1,":[248],"as":[249],"measured":[250],"These":[254],"data":[255],"provide":[256],"support":[257],"biomarker-driven":[260],"therapeutic":[261],"approach":[262],"select":[264],"T":[265],"that":[268],"dependent":[270],"MCL-1.":[272]},"counts_by_year":[],"updated_date":"2026-08-28T12:50:07.497085","created_date":"2020-03-06T00:00:00"}